TELA stock forecast
Our latest prediction for TELA Bio Inc's stock price was made on the Sept. 22, 2022 when the stock price was at 8.10$.
In the short term (2weeks), TELA's stock price should underperform the market by -2.52%. During that period the price should oscillate between -9.02% and +5.56%.
In the medium term (3months), TELA's stock price should outperform the market by 7.15%. During that period the price should oscillate between -31.66% and +31.18%.Get email alerts
Create a solid portfolio with TELA
About TELA Bio Inc
TELA Bio Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing patients with advanced, economically effective biologic material repair solutions to patients to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.
At the moment the company generates 70M USD in revenues.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is -0.79$
Three months stock forecastSept. 22, 2022
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|